LONG BEACH, Calif., Sept. 4, 2019 /PRNewswire/ -- SCAN Health Plan®, one of the nation's largest not-for-profit Medicare Advantage health plans, today announced

NASDAQ: CORV  TSX: CORV VANCOUVER, Sept. 4, 2019 /PRNewswire/ - Correvio Pharma Corp. (NASDAQ: CORV / TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced that Justin Renz, President and Chief Financial Officer of Correvio, will present at the H.C. Wainwright 21

MISSISSAUGA, ON, Sept. 4, 2019 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF), a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products, today announced that Jesse Ledger, Nuvo's President & Chief Executive Officer will present at the H.C. Wainwrig

DAVIS, Calif., Sept. 4, 2019 /PRNewswire/ -- Arcadia Biosciences, Inc. (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of cro

CUPERTINO, Calif., Sept. 4, 2019 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today that James E. Brown, Chief Executive Officer will be presenting at the 21st Annual Global Rodman and Renshaw Investment Conference, sponsored by H. C. Wainwright, at the Lotte New York Palace Hotel in N

WASHINGTON, Sept. 4, 2019 /PRNewswire/ -- Dr. Michael Greger, M.D., FACLM, the internationally-renowned nutrition expert, physician, founder of Nutritionfacts.org, and author of the bestselling book How Not to Die, has turned his attention to the latest research on the leading causes—and remedies—of obesity with his forth

WAYNE, Pa., Sept. 4, 2019 /PRNewswire/ -- Tekni-Plex has purchased automation equipment solutions manufacturer MMC Packaging Equipment Ltd. which will become part of Tekni-Plex's Tri-Seal business.

NEW YORK, Sept. 4, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH), a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from dermatological indications ranging from atopic dermatitis to chronic wound disorders, today issued a letter to shareholders.

Women seeking treatment for the most common form of female sexual dysfunction, Hypoactive (low) Sexual Desire Disorder (HSDD), now have greater access to the medical treatment Addyi  RALEIGH, N.C., Sept. 4, 2019 /PRNewswire/ -- Sprout Pharmaceuticals (Sprout) announced today that the U.S. Food and Drug Administration (FDA) has removed the

MONMOUTH JUNCTION, N.J., Sept. 4, 2019 /PRNewswire/ -- Tris Pharma, Inc. ("Tris"), a specialty pharmaceutical company with a robust portfolio of approved products and a late-stage pipeline of innovative product candidates for the treatment of Attention Deficit Hyperactivity Disorder and related disorders, announced the addition of two industry veterans to join its g